GPX4 and prostate carcinoma: Furthermore, this study reveals that SLC7A11 is highly expressed in prostate cancer; the SLC7A11/GPX4 signaling pathway regulates cellular ferroptosis, thereby influencing prostate cancer proliferation and metastasis.